Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
Recruiting · NCT06207370 · Registry updated 2025-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis | Infections, babesiosis, non-human animal disease, parasitic disease, non-human animal, parasitic infectious disease, protozoa infectious disease, protozoan infections, animal, tick-borne infectious disease, vector-borne disease | Recruiting | Phase 2 | 2025-11-21 | NCT06207370 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 60 Degrees Pharmaceuticals LLC | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tufts Medical Center | Boston | United States | 238 |